Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunhawk Vision BiotechROCO:7759 +0.33%20 Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus rates ROCO:7759 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 852 Biotechnology companies, Sunhawk Vision Biotech ranks worse than 117370.77% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Sunhawk Vision Biotech's Revenue for the
six
months ended in Jun. 2026 was NT$0.00 Mil. Sunhawk Vision Biotech's average Accounts Receivable for the
six
months ended in Jun. 2026 was NT$0.00 Mil.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Sunhawk Vision Biotech Receivables Turnover Related Terms
Sunhawk Vision Biotech Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Sunhawk Vision Biotech's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7759 vs VRTX, REGN, MRNA: Receivables Turnover Comparison
For the Biotechnology subindustry, Sunhawk Vision Biotech's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunhawk Vision Biotech Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunhawk Vision Biotech's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Sunhawk Vision Biotech's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunhawk Vision Biotech (ROCO:7759) has a Receivables Turnover of 0.00 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sunhawk Vision Biotech and its competitors. According to the industry distribution chart, Sunhawk Vision Biotech ranks #999999 out of 852 companies in the Biotechnology industry.
Is Sunhawk Vision Biotech's Receivables Turnover too high?
Sunhawk Vision Biotech's current Receivables Turnover is 0.00. Based on the distribution chart, Sunhawk Vision Biotech ranks #999999 out of 852 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sunhawk Vision Biotech has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Sunhawk Vision Biotech's Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunhawk Vision Biotech ranks #999999 out of 852 companies for Receivables Turnover. This places Sunhawk Vision Biotech in the lower half of its industry. The industry median Receivables Turnover is 5.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.28, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Sunhawk Vision Biotech and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunhawk Vision Biotech's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunhawk Vision Biotech stock overvalued right now?
Sunhawk Vision Biotech (ROCO:7759) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Sunhawk Vision Biotech's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Sunhawk Vision Biotech (ROCO:7759), the current Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunhawk Vision Biotech Inc is a biotechnology company. The company is focused on developing new solutions for eye health and vision care. The company specializes in research and development of cutting-edge technologies aimed at treating and preventing ocular diseases. Their product portfolio includes products and services for curing dry eyes, myopia, and corneal erosion.
20GF Score
Get the complete analysis for ROCO:7759
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7759 has been successfully added to your 
